Cutaneous sporotrichosis treated with methylene blue-daylight photodynamic therapy

J Eur Acad Dermatol Venereol. 2018 Mar;32(3):e90-e91. doi: 10.1111/jdv.14545. Epub 2017 Sep 14.

Authors

A J García-Malinis^{1

2}, A Milagro Beamonte³, L Torres Sopena³, O García-Callen², P Puertolas-Villacampa², Y Gilaberte¹

Affiliations

¹ Unit of Dermatology, San Jorge Hospital, Avenida Martinez de Velasco, 36, Huesca, Spain.
² Unit of Dermatology, Jaca Hospital, Avenida Rapitan sn, Jaca, Huesca, Spain.
³ Department of Microbiology, San Jorge Hospital, Avenida Martínez de Velasco, 36, Huesca, Spain.

PMID: 28846164
DOI: 10.1111/jdv.14545

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antifungal Agents / therapeutic use
Humans
Itraconazole / therapeutic use
Male
Methylene Blue / therapeutic use*
Photochemotherapy*
Photosensitizing Agents / therapeutic use*
Sporotrichosis / drug therapy*
Treatment Outcome

Substances

Antifungal Agents
Photosensitizing Agents
Itraconazole
Methylene Blue